BioSpace News Archive

Business

UCB Doubles Down on Rare Diseases with $1.9B Zogenix Deal

UCB has announced that it is acquiring Zogenix as part of plans to expand its reach into commercializing and developing treatments for rare diseases.

January 19, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Ceptur Launches U1 Adaptors with $75 Million Series A

The company’s co-Founder, President and CEO Dr. P. Peter Ghoroghchian, took time to discuss the company and the financing round with BioSpace.

January 19, 2022
·
4 min read
·
Mark Terry
Business

Hal Barron Departing GSK to Helm Bay Area Startup

Hal Barron, the man who guided the reinvigoration of the pharmaceutical direction at GSK, is departing the company to be the CEO of Altos Labs.

January 19, 2022
·
3 min read
·
Alex Keown
Drug Development

ImmunityBio Nant Pancreatic Cancer Vaccine Shows Promising Results

The new pancreatic cancer vaccine from ImmunityBio shows very promising results. Here’s what you need to know about the vaccine and its result from the tests.

January 19, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Yumanity Expresses Confidence as Parkinson’s Therapy Placed on Partial Hold

The FDA issued the partial clinical hold order in response to the IND application Yumanity submitted in December last year. The company expects additional data on the directive within the next 30 days.

January 19, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Companies Tout Cancer Treatments Coming Together in the Clinic

A checkpoint inhibitor under development from China’s CStone Pharmaceuticals hit the mark in a Phase III non-small cell lung cancer study.

January 19, 2022
·
4 min read
·
Alex Keown
Business

Engitix Nets $54M for Human Extracellular Matrix Drug Targets

The company plans to use the money to boost its drug discovery pipeline in fibrosis and cancer and expand its team, facilities and operations.

January 19, 2022
·
3 min read
·
Alvin Clavines
Depth Filtration Market To Reach USD 3.78 Billion By 2028 With CAGR of 9.3%, Says Reports And Data

Rising adoption of disposable filters, increasing use of single-use technologies, and rapid development of wastewater purification plants are key factors driving market growth.

January 19, 2022
·
7 min read
Drug Development

AstraZeneca Imfinzi-Tremelimumab Combo “Sets New Benchmark” in Liver Cancer

AstraZeneca has been struggling to find an effective use for its anti-CTLA-4 antibody tremelimumab. It may have finally found it.

January 19, 2022
·
3 min read
·
Mark Terry
Drug Development

Pfizer Antiviral Brings Game Against Omicron, Genetics for Loss of Smell/Taste ID’d

A study conducted by 23andMe and published in Nature Genetics identified a genetic risk factor tied to the loss of smell from COVID-19.

January 19, 2022
·
5 min read
·
Mark Terry